Wheeler Melissa, Patel Arti, Suresh Santhanam, Roth Andrew G, Birmingham Patrick K, Heffner Corri L, Coté Charles J
Department of Anesthesiology, Children's Memorial Hospital, The Feinberg School of Medicine, Northwestern University, Chicago, IL 60614, USA.
Paediatr Anaesth. 2005 Jun;15(6):476-83. doi: 10.1111/j.1460-9592.2005.01481.x.
In this prospective, randomized, double-blind study, we compared the efficacy of 0.125% bupivacaine and epinephrine 1:200,000 with and without clonidine 2 microg.kg-1 for 'single shot' pediatric caudal analgesia.
Thirty ASA I and II children, ages 2-8 years, undergoing outpatient surgical procedures below the umbilicus received 1 ml.kg-1 0.125% bupivacaine with fresh epinephrine 1:200,000 and clonidine 2 microg.kg-1 (group-C) or 1 ml.kg-1 0.125 % bupivacaine with epinephrine 1:200 000 (group-NC). All patients received a standardized general anesthetic (induction with 67% N2O in O2 and sevoflurane followed by isoflurane maintenance). Primary outcome measures were time to first rescue analgesic and number of patients requiring rescue analgesic at 4, 6, 8, 12, and 24 h after caudal placement. Secondary outcome measures included: extubation times, Objective Pain Scale (OPS) scores, sedation scores, time in postanesthesia care unit (PACU), discharge time, number of analgesic doses given in 24 h following caudal blockade, and adverse effects (vomiting, hypotension, and bradycardia).
There were no differences in demographics, investigated parameters, or adverse effects between groups.
We found that the addition of clonidine 2 microg.kg-1 to 0.125% bupivacaine with fresh epinephrine 1:200,000 for caudal analgesia did not significantly delay the time to first rescue analgesic or decrease the overall need for rescue analgesics in children 2-8 years undergoing surgical procedures below the umbilicus.
在这项前瞻性、随机、双盲研究中,我们比较了含与不含2微克/千克可乐定的0.125%布比卡因和1:200,000肾上腺素用于小儿“单次注射”骶管镇痛的疗效。
30例年龄2至8岁、ASA I级和II级、接受脐以下门诊手术的儿童,接受1毫升/千克的0.125%布比卡因加新鲜的1:200,000肾上腺素和2微克/千克可乐定(C组)或1毫升/千克的0.125%布比卡因加1:200,000肾上腺素(NC组)。所有患者均接受标准化全身麻醉(诱导用67%氧化亚氮和氧气及七氟醚,随后用异氟醚维持)。主要观察指标为骶管置管后4、6、8、12和24小时首次使用补救性镇痛药的时间以及需要补救性镇痛药的患者数量。次要观察指标包括:拔管时间、客观疼痛量表(OPS)评分、镇静评分、麻醉后恢复室(PACU)停留时间、出院时间、骶管阻滞后24小时内给予的镇痛药物剂量以及不良反应(呕吐、低血压和心动过缓)。
两组在人口统计学、研究参数或不良反应方面无差异。
我们发现,对于接受脐以下手术的2至8岁儿童,在0.125%布比卡因加新鲜的1:200,000肾上腺素用于骶管镇痛时添加2微克/千克可乐定,并未显著延迟首次使用补救性镇痛药的时间,也未减少补救性镇痛药的总体需求。